These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8610720

  • 1. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
    Tashkin DP, Bleecker E, Braun S, Campbell S, DeGraff AC, Hudgel DW, Boyars MC, Sahn S.
    Am J Med; 1996 Jan 29; 100(1A):62S-69. PubMed ID: 8610720
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
    Tashkin DP, Ashutosh K, Bleecker ER, Britt EJ, Cugell DW, Cummiskey JM, DeLorenzo L, Gilman MJ, Gross GN, Gross NJ.
    Am J Med; 1986 Nov 14; 81(5A):81-90. PubMed ID: 2947465
    [Abstract] [Full Text] [Related]

  • 6. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
    Karpel JP.
    Chest; 1991 Apr 14; 99(4):871-6. PubMed ID: 1672634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
    LeDoux EJ, Morris JF, Temple WP, Duncan C.
    Chest; 1989 May 14; 95(5):1013-6. PubMed ID: 2523291
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease.
    Tzelepis G, Komanapolli S, Tyler D, Vega D, Fulambarker A.
    Eur Respir J; 1996 Jan 14; 9(1):100-3. PubMed ID: 8834341
    [Abstract] [Full Text] [Related]

  • 11. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O, Manier G, Castaing Y.
    Monaldi Arch Chest Dis; 1998 Feb 14; 53(1):3-8. PubMed ID: 9632900
    [Abstract] [Full Text] [Related]

  • 12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep 14; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May 14; 105(5):1411-9. PubMed ID: 8181328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
    Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D.
    Pulm Pharmacol Ther; 2018 Feb 14; 48():71-79. PubMed ID: 28987804
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
    Karpel JP, Pesin J, Greenberg D, Gentry E.
    Chest; 1990 Oct 14; 98(4):835-9. PubMed ID: 2145136
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.